Faron Pharmaceuticals OY (FARN) NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
150.00p
153.00p
360.00p
£108.01 million
150.00p
147.20p
113.00p
n/a
0.00p (0.00%) Previous:
0.00p
6,926
n/a
750
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (€m) | n/a | n/a |
Profit before tax (€m) | (30.94) | (28.73) |
Adjusted EPS (¢): | (48.00) | (52.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: Euro
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Faron Pharmaceuticals extends funding agreement with IPF
30 April 2024 16:33
-
Faron Pharmaceuticals CFO stands down
15 April 2024 09:36
-
Faron Pharmaceuticals taps Juho Jalkanen for CEO
8 April 2024 09:17
-
Update on financial status
30 April 2024 14:00
-
Board Change
30 April 2024 13:00
-
Appointment of Chief Financial Officer
15 April 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.